New Zealand is so far behind with access to standard of care treatments it is embarrassing. Lung cancer is the most targetable cancer. However, Pharmac policy is causing our most vulnerable to die prematurely.
WHEN: Tuesday 7 May 2019 10.45 am to 1.00 pm WHERE: Meet at the courtyard, outside Wellington Library, 65 Victoria Street. We will march to Pharmac at 40 Mercer Street, then along Willis Street and Lambton Quay, before arriving on the steps of Parliament. Click the link to view our poster – LFNZ Petition Submission […]
Dear Supporter Lung cancer kills more people in New Zealand every year, than breast cancer, prostate cancer and melanoma cancer combined, yet it is the least funded. Right now, we are witnessing unprecedented suffering and inequity in New Zealand, resulting in premature death for the majority of patients diagnosed with lung cancer. Sadly, almost 1900 […]
Despite lung cancer being NZ’s Biggest Cancer Killer, the top 3 lung cancer drugs funded by Pharmac (2017/18) equates to just 2.3% of the top 5 cancer drugs ($122 million).
Please stand with us by signing this petition. Together we can call on the Government to declare lung cancer a health priority and to approve additional budget for Pharmac to fund lung cancer medications, including Keytruda, Alectinib, Osimertinib and Crizotinib, for all Kiwis with advanced lung cancer, irrespective of socio-economic status. https://www.parliament.nz/en/pb/petitions/document/PET_86322/petition-of-philip-hope-for-lung-foundation-new-zealand?fbclid=IwAR0Er6gNod70xvpB1kq3bBVa0LExrfq8GSWo7Gv3KvV-Jr9vwb8mL-NsrDs
Lung Foundation NZ has filed a submission with Pharmac, urging them to do better for lung cancer – NZ’s Biggest Cancer Killer. A staggering imbalance exists, because of underfunding by Pharmac. For example; the top 3 lung cancer drugs reimbursed in NZ, represents less than 3% of the top 5 cancer drugs funded, despite lung […]
Christine Roberts, 51, was diagnosed with stage four lung cancer in May 2017. This brave mother talks about her challenging cancer journey and her children. Christine has a message for Pharmac which is an instrument of government. http://https://drive.google.com/file/d/1QwSf4swQXLDNA4M9qVmUHhsuZNv0lsU-/view
The introduction of a lung cancer screening programme has the potential to improve health outcomes in New Zealand for NZ’s Biggest Cancer Killer. Data from the NELSON study which was presented at last year’s International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer (to which Lung Foundation NZ is affiliated) […]
Dr Chris Atkinson, Lung Foundation NZ, Medical Director & Associate Professor of Oncology A new approach, informed by equity, a must to improve outcomes for lung cancer – NZ biggest cancer killer. Watch our video here
Monday 19th November 2018 – Following a historic decision by Australia to fund untreated lung cancer patients, Lung Foundation New Zealand says it is extremely disappointed that Pharmac has made no decision on KEYTRUDA two years after making a funding application. 2018 19th November – Lung Foundation Media Release